Objective: The aim of this study was to examine the association between changes in blood oxidative stress level/ activity and changes in memory performance among postmenopausal women.
T he effect of hormone therapy (HT) on cognitive function remains inconclusive. Estrogen therapy has been shown to reverse memory impairment associated with estrogen deficiency and to lower the risk of developing dementia in many studies involving postmenopausal women. 1<13 In contrast, a number of studies found no protective effect of estrogen on either cognitive functioning 14<16 or dementia. 17<19 Recently, our group reported improvements in immediate memory, immediate memory after interference, and delayed recall after 16 weeks of estrogen-progestin therapy (EPT) in postmenopausal women. 20 It has been suggested that cognitive impairment is a consequence of imbalances between local reactive oxygen species and antioxidant capacity within the brain 21<23 and that an unbalanced accumulation of oxidatively modified proteins in the brain potentiates neurodegeneration and impairs cognitive function. 21, 24 The relationship between cognition impairment and oxidative stress is evident from the extensive damage caused by free radicals in age-related neurological conditions such as Alzheimer_s disease. 25, 26 Studies have shown that cognitive aging is significantly related to variance in the blood levels of lipid peroxidation.
27<31
The lipid peroxidation process has few end products, including malondialdehyde, 4-hydroxynonenal (4-HNE), 4-hydroxy-2-hexenal, and acrolein. 32 4-HNE was found to be neurotoxic and to inhibit enzymes critical for neuron survival, including Na + /K + ATPase, glucose, and glutamate transporters. 4-HNE can lead to changes in the alteration process of neurofibrillary tangles and has been shown to be involved in cognitive impairment. 33 There are many published studies on the effects of HT on the status of oxidative stress in postmenopausal women, 34<40 but little is known about its association with cognitive function. Recently, Ansari and Scheff 41 reported an association between oxidative stress levels and cognitive function in postmortem brain samples. Therefore, the present study aims to examine the association between changes in oxidative stress level/activity and changes in memory performance in postmenopausal women.
METHODS

Procedure and design
The study protocol was approved by the Research and Ethics Committee of Universiti Sains Malaysia. This study involved 39 postmenopausal women aged between 45 and 60 years who had their final menstrual period more than 1 year before study entry. The participants were recruited from the Family Medicine and the Obstetrics and Gynecology Clinic, Hospital Universiti Sains Malaysia. Participants were literate and were not taking any form of medication that could alter their memory function or any other herbal or hormone replacement 3 months before the study. Participants were not chosen if they smoked or had a history of drug or alcohol abuse or a history of serious medical, surgical, mental, or gynecological diseases. Participants underwent physical examinations, including pelvic ultrasonography, to exclude endometrial thickness.
Postmenopausal women who fulfilled the criteria were briefed on the nature of the study, and their consent to participate was taken. During the initial visit, blood was obtained to measure oxidative stress level/activity, and the participants' verbal learning and memory performance were assessed. The participants received Femoston Conti 1/5 (1 mg of 17A-estradiol plus 5 mg of dydrogesterone) for 16 weeks. Health status, compliance, and any possible adverse effects of EPT were monitored at 8 weeks. After 16 weeks, oxidative stress status and verbal learning and memory performance were reassessed.
Sample collection
Blood samples were collected into appropriate EDTA bottles to determine oxidative stress level/activity. A total of 150 KL of whole blood was used to determine the ratio of reduced glutathione (GSH) to oxidized glutathione (GSSG). The remaining blood was centrifuged at 1,000g for 10 minutes at 4-C to obtain plasma, aliquoted, and stored at j80-C until assayed.
Determination of memory performance
Participants' verbal learning and memory performance were assessed using the Malay Version of Auditory Verbal Learning Test (MVAVLT), as previously described. 20, 42 The participants were asked to listen to 15 nouns (list A). List A was read at a rate of one item per second (a tape recorder was used to standardize the delivery rate). The participants had to verbally repeat list A, and this trial was labeled as A1. The procedures were repeated for another four times. In each trial, the participants were asked to verbally repeat list A after each presentation, and these trials were labeled as A2 to A5. The second list (or list B) also contains 15 nouns presented to the participants, and the participants were asked to verbally repeat list B (B). A recall of list A was examined without prior presentation of the list by the examiner (A6). After 20 minutes of rest, the recall of list A was repeated also without prior presentation (A7). Lastly, participants had to recognize the words from list A, which were randomly interspersed among other words in a list composed of 30 words.
Determination of blood oxidative stress level/activity
The blood GSH-to-GSSG ratio and the plasma catalase (CAT), superoxide dismutase (SOD), and glutathione peroxidase (GPx) activities were determined using a commercially available kit (Calbiochem, Darmstadt, Germany). Plasma 4-HNE level was ascertained using the Oxiselect HNE-His adduct ELISA kit (Cell Biolaboratories, San Diego, CA). Procedures for the verification of antioxidant enzymes and lipid oxidative damage were in accordance with the manufacturer_s protocol. The intra-assay coefficients of variation for GSH, GSSG, CAT, SOD, GPx, and 4-HNE were 0.96%, 6.45%, 5.7%, 5.9%, 5.6%, and 4.0%, respectively.
Statistical tests
Results were analyzed using PASW Statistics version 18. Paired t test was used to examine differences in blood oxidative stress values before and after 16 weeks of EPT. r was used to examine the association between changes in blood oxidative stress level/activity and changes in memory performance. P G 0.05 was considered statistically significant.
RESULTS
A total of 39 postmenopausal women participated in this study, and the participants' characteristics are summarized in Table 1 .
The mean MVAVLT scores before and after 16 weeks of EPT were compared for each trial using paired t test, as shown in Table 2 . The mean scores for trials A1, A2, and A4 (immediate memory) were significantly increased when comparing before and after EPT (P G 0.05). The mean scores for total learning (summation of scores for trials A1-A5) were a significantly increased after EPT when compared with the baseline value (P G 0.05). The mean scores for trial A6 (immediate memory after interference with list B), trial A7 (delayed memory), and recognition memory were also significantly increased when contrasting before and after EPT (P G 0.05). An untreated control group was included for the assessment of memory performance to eliminate the possibility of learning effects. Comparison between the untreated control group and the EPT group showed a significant difference in mean MVAVLT scores for trial A1, trial A5, total learning, trial A6, and trial A7. The complete results had been published earlier. 20 Blood estradiol and oxidative stress levels/activities measured before and after EPT in postmenopausal women are summarized in Tables 3 and 4 , respectively. The serum estradiol levels of postmenopausal women were significantly increased after 16 weeks of EPT (P G 0.05).
The plasma CAT and GPx activities were extensively increased after 16 weeks of EPT (P G 0.05). The blood GSH-to-GSSG ratio, an indicator of oxidative stress, was reduced but was not statistically relevant. There seemed to be almost no change in plasma SOD activity after EPT. Plasma 4-HNE levels, however, showed considerable reduction after 16 weeks of EPT (P G 0.05).
r revealed no significant association between the changes in oxidative stress level/activity and the changes in trial scores, except for the changes in trial A2 scores (immediate memory) with changes in plasma SOD (r = 0.36, P G 0.05) and blood GSH-to-GSSG ratio (r = 0.34, P G 0.05; Table 5 ).
DISCUSSION
The serum estradiol levels of postmenopausal women were notably increased after 16 weeks of EPT. This finding supports the possibility of estrogen contributing to the memory improvement observed in postmenopausal women treated with EPT. 20 It is believed that estrogen improves cognitive function through its neuroprotective effects, and one of the potential mechanisms involves the powerful antioxidant properties of estrogen. 43 Estrogen acts directly through its phenolic hydroxyl group at the C3 position on the A ring of steroid molecules 44 and indirectly by increasing the levels of endogenous antioxidant enzymes. 45 17A-Estradiol has a chemical structure that is quite comparable to the lipophilic cellular antioxidant >-tocopherol (vitamin E). Both molecules have a phenolic free radicalYscavenging group and a lipophilic tail that mediates incorporation into membranes.
Similar to vitamin E, 17A-estradiol protects against oxidative damage 46 through direct quenching of reactive oxygen species, leading to reduced oxidative stress. 47 A significant increase in CAT activity occurred after 16 weeks of EPT. Increased CAT activity may indicate that this enzyme operated continuously to decompose hydrogen peroxide into harmless products. Recently, Ansari and Scheff 41 reported that CAT level was significantly decreased in the postmortem brains of participants with mild cognitive impairment and Alzheimer_s disease. Thus, it remains possible to suggest that estrogen indirectly increases CAT enzyme activity and improves memory performance in postmenopausal women with EPT. Nevertheless, our findings were contradictory to the findings of previous studies conducted in postmenopausal women. 35, 38, 39 Previous studies reported that CAT activity displayed minute differences neither between treated and nontreated postmenopausal women nor between premenopausal and postmenopausal women.
GPx activity was significantly increased after 16 weeks of EPT and was consistent with other studies. 36, 48 GPx level significantly increased in postmenopausal women after 3 months (n = 22) and 6 months (n = 20) of therapy with Premarin (0.625 mg/d for 25 d) and Provera (5 mg/d for 10 d). 36 In another study, Massafra et al 48 reported that erythrocyte GPx was extensively higher in premenopausal women (n = 90) than in postmenopausal women (n = 60). Estrogen may exert antioxidant effects via the modulation of intracellular GPx activity. 49 However, our results are inconsistent compared with those of previous studies that found no difference in GPx activities in postmenopausal women with and without HT 38, 50 and in the postmortem brains of participants with mild cognitive impairment and Alzheimer_s disease. 41 The GSH-to-GSSG ratio represents the glutathione redox status, an index of oxidative stress in all types of tissues, cells, and organelles. Under normal physiological conditions, the ratio is above 10. 51 In this study, the GSH-to-GSSG ratio was above the physiological level both before and after the intervention. However, the ratio was found to be reduced in postmenopausal women after 16 weeks of EPT. The GSHto-GSSG ratio will decrease as a consequence of GSSG Values are expressed as mean (SEM). Statistical comparisons before intervention and after intervention were performed using paired t test. GSH, reduced glutathione; GSSG, oxidized glutathione; SOD, superoxide dismutase; CAT, catalase; GPx, glutathione peroxidase; 4-HNE, 4-hydroxynonenal. a P G 0.05 was considered statistically significant. accumulation 51, 52 when exposed to increased oxidative stress. Through EPT, depletion of GSH, together with evidence of increased GPx, suggests an ongoing process to detoxify oxidative stress. The present study revealed a significant positive correlation between the changes in the blood GSH-to-GSSG ratio and the changes in trial A2 scores. This finding implies that when the oxidative stress level decreased (as shown by an increased blood GSH-to-GSSG ratio), immediate memory performance improved (as shown by increased trial A2 scores). This finding is supported by previous studies, which revealed that older persons in urban areas had more oxidative stress and a higher risk of developing cognitive impairment when compared with older persons living in rural communities. 53 The plasma SOD level was almost unchanged after 16 weeks of EPT, but there was a significant positive correlation between the changes in plasma SOD level and the changes in trial A2 scores. A study conducted by Ansari and Scheff 41 revealed that the changes in antioxidant levels (ie, GSH, SOD, and CAT) strongly correlated with the Mini Mental State Examination score, supporting the idea that major changes in oxidative stress compose an early event that plays an imperative role in the progression of the disease. Our results are inconsistent, however, with those of previous studies, which showed either an increase or a decrease in SOD levels with HT. Unfer et al 39 showed an increase in SOD levels to premenopausal levels in postmenopausal women treated with HT compared with postmenopausal women without HT. Other studies, however, showed a reduction in SOD levels after 6 months of HT. 36 The present study revealed a reduction in plasma levels of 4-HNE, a marker for lipid peroxidation, after 16 weeks of EPT, consistent with the findings from a previous study. 4 -HNE has been shown to be associated with cognitive impairment. 33 It is consistent with our findings that a decrease in plasma 4-HNE levels was related to improved memory performance among postmenopausal women treated with EPT.
In the present study, the increase in the main antioxidant enzyme activities reduces the production of hydrogen peroxide and reactive hydroxyl radicals and thus reduces oxidative stress damage. The changes in peripheral antioxidant activities may reflect similar changes in the brain regions related to the memory function of postmenopausal women treated with EPT. These findings may shed light on the possible neuroprotective roles of estrogen in memory function, consistent with previous imaging studies. Positron emission tomography studies indicate that HT modulates the pattern of regional cerebral blood flow activation in brain regions that play critical roles in memory processing and shows that hypoperfusion occurs in individuals who are at an increased risk of developing Alzheimer_s disease 54<56 and who are in the early stages of the disease. 57 Shaywitz et al 58 reported HT effects on functional magnetic resonance imaging activation patterns during the performance of verbal and visual working memory tasks, similar to the findings in positron emission tomography studies.
Limitations of the present study include the absence of an age-matched control group for changes in blood oxidative stress level/activity and the fact that the effects on blood oxidative stress level/activity were not specified to different stages of menopause. We were unable to control for certain factors, such as diet, exercise, and health status, that were known to alter oxidative stress level/activity and in turn may exert direct or indirect effects on memory performance. Therefore, in the present study, the baseline (before intervention) values of the oxidative stress markers were used as control values for each participant.
We suggest future causal relationship studies using a larger sample size with age-matched controls and a longer duration of EPT to confirm the association between the changes in oxidative stress and the changes in the memory performance of postmenopausal women at different stages of menopause.
CONCLUSIONS
Sixteen weeks of EPT reduce oxidative stress and improve memory performance in postmenopausal women. It is unclear whether the direct antioxidant properties of estrogen or its indirect effects through increased plasma CAT and GPx activities are capable of reducing oxidative stress. The association between the changes in the plasma level/activity of oxidative stress and the changes in memory performance is unremarkable. Only plasma SOD levels and the blood GSHto-GSSG ratio are positively correlated with the changes in immediate memory performance. 
